$1.22
-0.01[-0.81%]
At close: Apr 19
$1.22
0[0.00%]
After Hours: 5:56PM EDT
Aclaris Therapeutics
(NASDAQ:ACRS)Aclaris Therapeutics Stock (NASDAQ:ACRS), Quotes and News Summary
Aclaris Therapeutics Stock (NASDAQ: ACRS) stock price, news, charts, stock research, profile.
| Open | $1.230 |
| Close | $1.240 |
| Volume / Avg. | 579.779K / 1.176M |
| Day Range | 1.210 - 1.250 |
| 52 Wk Range | 0.590 - 11.120 |
| Market Cap | $86.529M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 51 |
| Short Interest | 7.95% |
| Days to Cover | 6.43 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Aclaris Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United S...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aclaris Therapeutics (ACRS) stock?
You can purchase shares of Aclaris Therapeutics (NASDAQ: ACRS) through any online brokerage.
Who are Aclaris Therapeutics's (ACRS) competitors?
Other companies in Aclaris Therapeutics’s space includes: Rani Therapeutics Hldgs (NASDAQ:RANI), Marinus Pharma (NASDAQ:MRNS), Alimera Sciences (NASDAQ:ALIM), Anebulo Pharmaceuticals (NASDAQ:ANEB) and Trevi Therapeutics (NASDAQ:TRVI).
What is the target price for Aclaris Therapeutics (ACRS) stock?
The latest price target for Aclaris Therapeutics (NASDAQ: ACRS) was reported by HC Wainwright & Co. on Monday, January 22, 2024. The analyst firm set a price target for 0.00 expecting ACRS to fall to within 12 months (a possible -100.00% downside). 16 analyst firms have reported ratings in the last year.
Current Stock Price for Aclaris Therapeutics (ACRS)?
The stock price for Aclaris Therapeutics (NASDAQ: ACRS) is $1.22 last updated April 19, 2024 at 5:56 PM EDT.
Does Aclaris Therapeutics (ACRS) pay a dividend?
There are no upcoming dividends for Aclaris Therapeutics.
When is Aclaris Therapeutics (NASDAQ:ACRS) reporting earnings?
Aclaris Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
Is Aclaris Therapeutics (ACRS) going to split?
There is no upcoming split for Aclaris Therapeutics.
What sector and industry does Aclaris Therapeutics (ACRS) operate in?
Aclaris Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.